Nirsevimab assigned Schedule II statusThe injectable monoclonal antibody prevents respiratory syncytial virus in newborns and infants during their first RSV season and at-risk children during their second RSV season. Three new drug indications physicians and pharmacists should know aboutGet the info you need on these new indications as part of our drug news roundup for October. NEW IUD: Yanae Cu 380 Get the info you need on this new product, part of our drug news roundup for October. NEW DRUG: Ferinject for iron deficiency Get the info you need on this new product, part of our drug news roundup for October. New dosage form for Quillivant ER Oral Suspension Get the info you need on this new dosage for as part of our drug news roundup for October. Health Canada advisory: SGLT2 inhibitors and prolonged or incident diabetic ketoacidosis Take note of this Health Canada advisory as part of our October drug news update. NEW DRUG: Wyost approved for two cancer-related indications Get the info you need on this new product, part of our drug news roundup for October. NEW DRUG: Jubbonti approved for several indications Get the info you need on this new product, part of our drug news roundup for October. NEW DRUG: Cabtreo: topical triple-therapy for acne Get the info you need on this new product, part of our drug news roundup for October. NEW DRUG: Asparlas for acute lymphoblastic leukemia Get the info you need on this new product, part of our drug news roundup for October. First Previous 20 21 22 23 24 Next Last
